Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial

[Image: see text] Introduction: Bromhexine is a potential therapeutic option in COVID-19, but no data from a randomized clinical trial has been available. The present study aimed to evaluate the efficacy of bromhexine in intensive care unit (ICU) admission, mechanical ventilation, and mortality in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Ansarin, Khalil, Tolouian, Ramin, Ardalan, Mohammadreza, Taghizadieh, Ali, Varshochi, Mojtaba, Teimouri, Soheil, Vaezi, Tahere, Valizadeh, Hamed, Saleh, Parviz, Safiri, Saeid, Chapman, Kenneth R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502909/
https://www.ncbi.nlm.nih.gov/pubmed/32983936
http://dx.doi.org/10.34172/bi.2020.27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502909/
https://www.ncbi.nlm.nih.gov/pubmed/32983936
http://dx.doi.org/10.34172/bi.2020.27

Ejemplares similares